title: Same-day transfer of patients with unstable angina and non-ST segment elevation myocardial infarction back to their referring hospital after angioplasty.
abstract: BACKGROUND
  Recent evidence has shown the advantages of an early invasive strategy for patients with high-risk unstable angina (UA) and non-ST segment elevation myocardial infarction (NSTEMI). However, the number of beds available for postangioplasty monitoring limits the use of this approach at the Centre hospitalier universitaire de Sherbrooke (Fleurimont, Quebec).
  
  
  OBJECTIVE
  To study the safety of a protocol allowing the same-day return of patients with UA or NSTEMI to their referring hospital after angioplasty at the Centre hospitalier universitaire de Sherbrooke.
  
  
  METHODS
  From June 2001 to June 2003, of the 532 patients with UA and NSTEMI who underwent percutaneous coronary intervention with planned same-day transfer back to their referring hospital, 419 consecutive patients who were eligible to return the same day were prospectively followed for 24 h.
  
  
  RESULTS
  Stents were used in 94.7% of patients and platelet glycoprotein IIb/IIIa receptor antagonists were used in 34.8% of patients. For 85% of patients, the femoral artery was used as the access route for percutaneous coronary intervention. The mean time that patients stayed in the hospital after angioplasty before returning to their referring centres was 4.4 h. No deaths, life-threatening arrhythmias or urgent revascularizations were reported during the 24 h postangioplasty follow-up period, but one patient had a major bleeding complication. During the study period, the mean angioplasty waiting time decreased from 5.7 days to 2.1 days.
  
  
  CONCLUSIONS
  The protocol evaluated in the present article is safe. It frees more beds, thus reducing the waiting list and allowing patients with high-risk acute coronary syndromes without ST segment elevation from community hospitals to benefit from the advantages of an early invasive strategy.
authors.affiliation: Division of Cardiology, Centre Hospitalier Universitaire de Sherbrooke, Fleurimont, Québec, Canada.
authors.forename: Doan Hoa
authors.initials: DH
authors.lastname: Do
authors.forename: Karl
authors.initials: K
authors.lastname: Dalery
authors.forename: André
authors.initials: A
authors.lastname: Gervais
authors.forename: Richard
authors.initials: R
authors.lastname: Harvey
authors.forename: Serge
authors.initials: S
authors.lastname: Lepage
authors.forename: Andrée
authors.initials: A
authors.lastname: Maltais
authors.forename: Michel
authors.initials: M
authors.lastname: Nguyen
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000789:Angina, Unstable / Q000628:therapy*; D015906:Angioplasty, Balloon, Coronary / Q000592:standards* / Q000706:statistics & numerical data; D002309:Cardiology / Q000592:standards; D002985:Clinical Protocols; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007902:Length of Stay / Q000706:statistics & numerical data; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000628:therapy*; D010043:Outcome and Process Assessment, Health Care; D010360:Patient Transfer / Q000592:standards* / Q000706:statistics & numerical data; D011446:Prospective Studies; D011792:Quebec; D012017:Referral and Consultation / Q000706:statistics & numerical data